New therapeutic approach for Duchenne muscular dystrophy combines LED therapy with idebenone

FHS
June 14, 2024
3:42 pm

In an animal model of Duchenne muscular dystrophy, Brazilian researchers tested a therapy that combines photobiomodulation using laser light or light-emitting diodes (LEDs) with idebenone, an antioxidant compound investigated for application in neurodegenerative diseases.

OcuTerra’s diabetic retinopathy drug fails PhII; Better Therapeutics to shut down

Plus, news about Immuneering, Aditum Bio, Unicycive and X-Therma: OcuTerra Therapeutics’ diabetic retinopathy drug fails PhII: The company’s RGD integrin inhibitor did not meet the

March 15, 2024

Predicting Preeclampsia; Using AI to Treat Atrial Fibrillation

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,

February 23, 2025

Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax – Biotech Investments

EQS-News: ABIVAX / Key word(s): Personnel Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax 13.11.2024 / 22:01 CET/CEST

November 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.